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Abstract 
Estrogen, is involved in much of the life 
women lives, having great importance in many 
functions of the female body including the 
definition of secondary sexual characters, but 
also has been linked as protective factor regard 
to catastrophic events such as cerebral 
aneurysms, probably related to estrogen 
deficiency and described high incidence in 
menopausal women. It is known the effects of 
estrogen on vascular physiology and 
pathophysiologic mechanisms with potential 
therapeutic implications. We present a brief 
review focused in the role of estrogens and the 
rupture of cerebral aneurysms. 
Key words: estrogen, cerebral aneurysms, 
deficiency, menopause. 
Introduction 
About 20% of strokes are hemorrhagic 
events, from these subarachnoid hemorrhage 
(SAH) accounts for 10% the remaining half 
corresponds tointracerebral hemorrhage. It is 
known that cerebral aneurysms are more 
common in women; numerous studies suggest 
the involvement of hormones in its 
pathogenesis. Studies have shown that oral 
contraceptives and hormone replacement 
therapy may be protective against aneurysmal 
subarachnoid hemorrhage suggesting that 
cyclical hormonal fluctuations in the context 
of physiological menses are associated with 
cerebral vascular instability and then the 
formation of cerebral aneurysms. Most causes 
SAH are ruptured berry aneurysms. Other 
causes include trauma, arteriovenous 
malformations, vasculitis, intracranial arterial 
dissections, amyloid angiopathy, bleeding 
diathesis, and illegal psychoactive substances 
such as cocaine and amphetamines. The aim of 
this work is to review the current kwnoledge 
regard aneurysms of the cerebral vasculature 
and their relationship with estrogen. 
Subarachnoid hemorrhage 
SAH is one of the most catastrophic   
intracranial events that may suffer an 
individual to whichneurosurgeons are 
routinely faced. It is defined as the occupation 
or invasion of blood in the subarachnoid 
space, where normally circulates the 
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cerebrospinal fluid (CSF). Aneurysmal 
rupture leads the patient to a critical state, with 
high probability of mortality. The care and 
management of patients with subarachnoid 
haemorrhage is vital to the successful 
development, as well as a multidisciplinary 
approach where participating neurosurgeons 
and endovascular neurosurgeons should be 
experienced in the microsurgical management 
of cerebral aneurysms. 
Epidemiology 
It is located within the pathologies that 
inevitably must handle any physician, 
affecting 6-10 people per 100,000 per year, 
although this range can varie (depending on 
the studies), in Finland, there have been 
incidents that reach 20/100.000 patients/ Year. 
(2) 
The most common age of onset is around 
55 years, increasing incidence with increasing 
age. It is also more common in women. 
(2)According to retrospective studies, among 
all patients who attend the emergency 
department with headache, subarachnoid 
hemorrhage is the cause in 1% of cases. 
Considering only patients with the worst 
headache of their lives and normal physical 
examination, this figure rises to 12%. This 
ratio increases again taking into account the 
patients with abnormal physical examination, 
reaching 25%. (3) 
It is a severe disease with a mortality rate of 
approximately 20 to 40% of inpatients plus 8-
15% mortality in the first minutes or hours, in 
the prehospital phase. (3) 
 
 
Etiology 
This process can be a pathological entity 
subsequent to trauma or occur spontaneously. 
Being the main cause of the latter rupture of an 
aneurysm in the brain stem (85% of cases) (4). 
The causes of spontaneous SAH are 
saccular aneurysm rupture (85%), ruptured 
arteriovenous malformation (8% -10%), 
unknown etiology (10%) and other rare 
(hypertension, arteritis, tumors, cardiac 
myxoma, and septic aneurysms). (4) 
Cerebral aneurysms are saccular 
dilatations of the arterial wall that are located 
at the forks of the basal subarachnoid brain 
arteries or near the circle of Willis. They 
originate from sites where there is a birth 
defect of the middle layer and the inner elastic 
membrane. 
Several modifiable risk factors have been 
identified in relation to the HSA. 
Clinical features 
The signs and symptoms of this disease are 
of sudden onset, in an individual who usually 
had no previous neurological disorders.  
The onset of symptoms is often preceded 
by intense physical activity or sexual activity, 
although it was noted that in a series of 500 
patients with subarachnoid hemorrhage, in 
34% of cases developed during stressful 
activities and 12% were produced during sleep. 
Headache, which is the most common 
symptom, is presented as sudden onset and 
intense, usually referred as the worst. Often is 
accompanied by nausea and vomiting. They 
can have any location, can be localized or 
generalized, may be mild and resolve 
spontaneously, may be relieved or non-
relieved by non-narcotic analgesics. Facing the 
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first or worst headache and an unusual 
headache in a patient with an established 
pattern of pain, SAH should be suspected until 
proven otherwise. 
Estrogen 
Estrogens are female sex hormones that 
participate in a variety of actions on different 
tissues. Among others, stimulate the 
development of female secondary sex 
characteristics, are involved in the 
characterization of the female physiognomy, 
adapting fatty deposits at the hips, thighs and 
development of internal and external genitalia. 
It acts on endometrial proliferation and 
growth of the uterus during the menstrual 
cycle in the cornification of the superficial cells 
of the vaginal mucosa, increases the secretion 
of cervical mucus to have the crossing of the 
sperm through the cervical mucus. 
Estrogens alter serum lipid levels, the 
fibrinolytic system and coagulation, 
antioxidant systems, and the production of 
vasoactive molecules, influencing the 
development of vascular disease. (1). However, 
direct exert pleiotropic effects on endothelial 
cells, collagen vascular smooth muscle 
constituent, and a potent vasodilator called 
nitric oxide (NO), thus contributing, together 
with other substances, the normal homeostatic 
process that allows endothelial remodeling 
arteries to maintain a constant diameter of the 
lumen, and therefore laminar blood flow 
strong enough for proper irrigation to distant 
structures. Thanks to this, with any noxious 
event affecting the vasculature, endothelial 
cells have the ability to counteract all processes 
efficiently generated. 
Atherosclerosis, which is a late 
consequence of all inflammatory and oxidative 
processes generated in endothelial cells has 
been associated with the formation, growth 
and ruptured aneurysms in any location. 
Although not yet demonstrated a direct causal 
link between the two mechanisms, 
histopathological findings of the 
atheromatous plaque have been identified in 
some samples of intracranial aneurysm wall, a 
fact that has allowed these inflammatory 
phenomena gain importance, taking into 
account that could be a therapeutic target in 
the pathogenesis of aneurysmal 
cerebrovascular disease.  
The sequence of inflammatory phenomena 
at endothelial level can be described as follows: 
endothelial dysfunction, vasoconstriction, 
leukocyte and monocyte adhesion, increased 
vascular permeability, monocyte migration 
and leukocytes, programmed cell death, 
release of proteolytic enzymes. It is not known 
with certainty how the metabolic pathway of 
estrogen reduce vascular tone, by direct action 
of NO and prostacyclin and inhibit monocyte 
adhesion to the endothelial wall by reducing 
plasma levels of the molecules VCAM-1 and 
MCP -1. The latter is probably due to 
inhibition in the expression of genes that 
produce such molecules, after intercepting the 
nuclear transcription factor NF-κβ. 
Furthermore, it is suspected that it is also 
responsible for the inhibition of MMP-2 and 
MMP-9, two major metalloproteinases that 
destroy the collagen and elastin of smooth 
muscle located in the arterial wall. 
All these actions are performed through 
the interaction of the hormone with its specific 
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receptor. There are four different types: ER-α, 
ER-β (which are activated by ligands) IPG 
(also called GPR 30, which is coupled to 
protein G), and ER-X , all available at level of 
the endothelial cells of the cerebral 
vasculature. 
Estrogens are able to directly influence the 
fallopian tube, muscle, breast cancer, pituitary 
gland, bone, smooth muscle, ion transport 
mechanisms, among others. 
In the uterus, increases spontaneous 
contractions expanding the excitation of 
oxytocin in the tubes, increases in size, and 
breast in turn, lead to a proliferation of ducts. 
In the hypothalamus, are responsible for the 
secretion of LHRH and dopamine, through 
which reduced gonadotropin levels also 
stimulate the production of prolactin, however 
limit their actions on the breast, also favor the 
presence of receptors for FSH the hair and 
become more sensitive to their stimulating 
hormone pituitary hypothalamic LHRH. 
Bones, provide mineralization, regularized 
long bone growth, cartilage conjunction closed 
and therefore cease growing. On the vascular 
system, estrogens may align or alter the ionic 
fluxes, receivers and reproduction property of 
vascular smooth muscle cells, and also regulate 
the release of endothelium-derived vasoactive 
factors. Thus, estrogen increases competition 
gear dependent vasodilator NO and 
prostacyclin, reduce the effectiveness of 
vasoconstrictors mechanisms, namely 
prostaglandins, RAAS (renin angiotensin 
aldosterone system), endothelin-1 (there is 
conflicting evidence on this ), involved in ion 
channel K + and Ca2 + in the cells of the 
vascular smooth muscle (VSMC), prompting 
hyperpolarization and decreasing its 
contraction, worth noting the actions of 
estrogen on the lipid profile, they are able to 
reduce the plasma concentration of LDL and 
increase HDL.  
Estrogens are hormones quintessential 
female puberty as they provide the 
characteristic distribution of body fat, which 
distinguish the female physiognomy 
predominantly around the hips and thighs of 
the male, which is mainly abdominal. 
It is seen that the activity of these hormones 
are present in most of women's lives, play an 
essential role in the biology of the vascular 
system and its mechanisms may represent 
beneficial results, however, is questioned their 
involvement in the pathophysiology of 
intracranial aneurysms (1). 
The fact that cerebral aneurysms are more 
common in women is not new. 
Epidemiological data indicate a high incidence 
of cerebral aneurysms in postmenopausal 
women (2-3). Numerous studies on the 
involvement of hormonal factors had treated 
the pathogenesis of aneurysms, is known the 
great participation of estrogen at different 
stages of the life of the woman, the great 
interaction between them and the vascular 
biology and although these interactions 
charities are largely still considers its 
involvement in the pathophysiology of 
cerebral aneurysms and catastrophic health of 
women. (4) (5) (1) 
Endothelial and hormonal physiology 
The endothelium is a layer of tissue which 
covers all the vessels of the body. Endothelial 
cells have a selective permeability, having  
non-thrombogenic properties, substantial 
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metabolic activity and  the ability to produce 
various vasoactive substances. In this way, the 
most important properties that can be 
identified on the endothelium are: 
• Selective permeability: Forms a highly 
selective permeability barrier, regulating the 
flow of nutrients, bioloigcamente active 
molecules and blood cells. (7). 
• Maintenance balance between 
thrombosis and fibrinolysis. 
Progression of the disease 
Cerebrovascular disease is favored by 
oxidative stress, increases inflammation, and 
may trigger processes that contribute to the 
formation and subsequent rupture of an 
aneurysm, as direct endothelial injury, 
phenotypic change of smooth muscle cells to a 
phenotype of inflammatory and Finally the 
radical apoptosis. Free radicals are also able to 
activate the matrix metalloproteinases getting 
vessel remodeling and decomposition. These 
radicals in turn involved in all mechanisms 
responsible for cerebral aneurysm, such as 
atherosclerosis, hemodynamic stress and 
hypertensive pathology that makes it through 
the mechanism of peroxidation. Thus, some 
preliminary studies involving targeted 
therapies to oxidative stress as a beneficial 
therapeutic option for treating cerebral 
aneurysms future, however, recent studies 
point to define the role of free radicals in the 
formation and rupture of a cerebral aneurysm. 
(6) 
Estrogen and brain aneurysm formation 
The hypothesis regarding the alterations in 
hormone levels can influence the SAH is 
gaining momentum rapidly. Specifically, the 
concept that post-menopausal women are 
more susceptible to the condition has 
convinced many of the protective roles of 
estrogen and progesterone (7). 
The task of the estrogen is very important 
for vascular biology; its beneficial effects are 
well known but not participating in the 
pathogenesis of cerebral aneurysms (1). 
Progression is associated with endothelial 
damage (2) to inflammation, impaired 
extracellular matrix and extracellular wall 
apoptosis, also in this process have been 
described as statins growth initiation 
mechanism and the aneurysm. (8) 
Variations of estrogen level have been 
associated with the development and 
progression and rupture of cerebral 
aneurysms, which could explain the gender 
gap regarding the higher incidence found in 
women. In a case-control study which 
interviewed 4,682 women, mostly observed 
premature menopause (<40 years) associated 
with aneurysm formation, which suggests that 
reducing estrogen may be premature in 
training a cerebral aneurysm. This in turn may 
lead to a risk factor to explain the 
pathophysiology of cerebral aneurysms and 
for long term therapies. 
The growth in the incidence of cerebral 
aneurysms in postmenopausal women can 
relate diminished circulating estrogen levels. 
In a rat model, for example, which induced the 
formation of the aneurysm, the researchers 
found that in oophorectomized models 
increased incidence of cerebral aneurysms (9) 
Involving the renin-angiotensin (Ang)-
aldosterone in the pathology of vascular 
disease has also been described. However 
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incommunicado mineralocorticoid receptor 
protects against vascular diseases, their 
influence on brain aneurysms is unclear. In a 
study used female rats which were induced by 
renal hypertension, increased hemodynamic 
stress, and they were subjected to insufficient 
estrogen for 3 months with the 
mineralocorticoid receptor blocker 
eplerenone (30 or 100 mg / kg per day) or 
vehicle (vehicle control) was observed as 
eplerenone reduced the incidence of cerebral 
aneurysms and saline intake without reducing 
blood pressure. On the wall of the aneurysm, 
increased production of Ang II and 
nitrotyrosine. MRNA levels of Ang-converting 
enzyme 1 and NADPH (10) 
Gender inequalities in the progression of 
aneurysmal subarachnoid hemorrhage (SAH) 
are discussed, and the possible influence of 
estradiol on vasodilation is not well defined. 
(11) Large number of studies suggests that 
hormones are important in the pathogenesis 
of an aneurysm. Estrogen raises the normal 
physiological vascular endothelial 
employment, and waves during the menstrual 
cycle as well as drops significantly at 
menopause, which would explain such  
relationship (5). 
Neuroprotective factors 
Evidence for a protective role of estradiol in 
neurodegenerative diseases has increased 
steadily over the past decade, although the 
mechanisms of action and participation of 
estrogen receptors (ER) showed a complex 
result. The protective effects of estrogens take 
place partly through pathways involving 
activation of canonical ER, which is 
constitutively expressed in many brain regions 
and is capable of initiating transcription of 
genes after specifically bind estradiol. 
Furthermore, non-genomic pathways (or 
alternative), involving extranuclear RE 
respond to physiological concentration of 
estrogen to induce neuroprotection. Often, 
rapid activation of intracellular signaling, such 
as mitogen activated protein kinase (MAPK) 
and phosphatidylinositol 3-kinase (PI3K) 
underlying estrogen-induced neuroprotection 
alternative activation of specific binding sites 
in the plasma membrane. Although the 
molecular characteristics of these 
unconventional ERs are still largely unknown, 
the conventional wisdom holds that the 
plasma membrane ER (MER) arises from or 
relates to, classical nuclear ER. This article 
reviews some of the latest evidence that reveals 
the importance of alternative mechanisms for 
estrogen-dependent neuroprotection. Special 
attention to models of cellular toxicity of beta-
amyloid in classical and alternative pathways 
activated by estrogens seem to exist to 
orchestrate neuroprotection. (12). 
Conclusions 
Knowledge of the cellular mechanisms 
involved in the possible involvement of 
estrogen and cerebral aneurysm formation will 
be an interesting line of research that may offer 
additional treatment alternatives for patients 
with incidental aneurysms or in patients at risk 
for brain aneurysms. 
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